• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活动性感染与病态肥胖患者的非酒精性脂肪性肝炎独立相关。

Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

作者信息

Doulberis Michael, Srivastava Simone, Polyzos Stergios A, Kountouras Jannis, Papaefthymiou Apostolis, Klukowska-Rötzler Jolanta, Blank Annika, Exadaktylos Aristomenis K, Srivastava David S

机构信息

Department of Gastroenterology and Hepatology, University of Zurich, Zurich 8091, Switzerland.

Second Medical Clinic, School of Medicine, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki 54642, Macedonia, Greece.

出版信息

J Clin Med. 2020 Mar 30;9(4):933. doi: 10.3390/jcm9040933.

DOI:10.3390/jcm9040933
PMID:32235601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7230908/
Abstract

Nonalcoholic fatty liver disease (NAFLD) emerges as an important global burden and infection (-I) has been suggested as a risk NAFLD, although controversy exists. This retrospective study aimed to investigate a potential impact of active -I on NAFLD severity in morbidly obese patients, subjected to bariatric surgery and gastric biopsy for documentation of -I. Of 64 eligible participants, 15 (23.4%) were diagnosed with active -I, showing higher rates of nonalcoholic steatohepatitis (NASH) than those without -I (86.7% vs. 26.5%, respectively; < 0.001). Concerning histological lesions, steatosis grade ( = 0.027), ballooning ( < 0.001), lobular inflammation ( = 0.003), and fibrosis stage ( < 0.001) were also more severe in -I positive patients. Likewise, liver function tests, insulin resistance, dyslipidemia, and arterial hypertension were significantly higher in -I positive patients. -I was independently positively associated with NASH (beta = 3.27; = 0.002), severe NASH (beta = 2.37; = 0.018), and the presence of fibrosis (beta = 3.86; = 0.001) in a binary regression model, after adjustment for potential confounders. In conclusion, active -Ι was independently associated with NASH and fibrosis, findings offering potential clinical implication.

摘要

非酒精性脂肪性肝病(NAFLD)已成为一项重要的全球负担,尽管存在争议,但感染(-I)已被认为是NAFLD的一个风险因素。本回顾性研究旨在调查活动性-I对病态肥胖患者NAFLD严重程度的潜在影响,这些患者接受了减肥手术并进行了胃活检以记录-I情况。在64名符合条件的参与者中,15名(23.4%)被诊断为活动性-I,其非酒精性脂肪性肝炎(NASH)的发生率高于无-I者(分别为86.7%和26.5%;<0.001)。关于组织学病变,-I阳性患者的脂肪变性分级(=0.027)、气球样变(<0.001)、小叶炎症(=0.003)和纤维化分期(<0.001)也更严重。同样,-I阳性患者的肝功能检查、胰岛素抵抗、血脂异常和动脉高血压也显著更高。在对潜在混杂因素进行调整后,在二元回归模型中,-I与NASH(β=3.27;=0.002)、重度NASH(β=2.37;=0.018)和纤维化的存在(β=3.86;=0.001)独立呈正相关。总之,活动性-Ι与NASH和纤维化独立相关,这些发现具有潜在的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194b/7230908/be905045305f/jcm-09-00933-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194b/7230908/6a64fa8aa160/jcm-09-00933-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194b/7230908/be905045305f/jcm-09-00933-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194b/7230908/6a64fa8aa160/jcm-09-00933-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194b/7230908/be905045305f/jcm-09-00933-g002.jpg

相似文献

1
Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.活动性感染与病态肥胖患者的非酒精性脂肪性肝炎独立相关。
J Clin Med. 2020 Mar 30;9(4):933. doi: 10.3390/jcm9040933.
2
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.幽门螺杆菌感染与非酒精性脂肪性肝病。
Metabolism. 2013 Jan;62(1):121-6. doi: 10.1016/j.metabol.2012.06.007. Epub 2012 Jul 27.
3
The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease.幽门螺杆菌感染与非酒精性脂肪性肝病之间的关联
Curr Gastroenterol Rep. 2017 Feb;19(2):5. doi: 10.1007/s11894-017-0545-1.
4
Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study.结合珠蛋白 2-2 基因型与非酒精性脂肪性肝炎患者疾病更严重相关:一项回顾性研究。
Adv Ther. 2019 Apr;36(4):880-895. doi: 10.1007/s12325-019-00902-z. Epub 2019 Feb 28.
5
Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.病态肥胖青少年非酒精性脂肪性肝病的组织学谱
Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32. doi: 10.1016/s1542-3565(05)00978-x.
6
Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study.幽门螺杆菌根除对非酒精性脂肪性肝炎患者肝脂肪变性、非酒精性脂肪性肝病纤维化评分及肝脂肪变性无创评分指数的影响:一项基于磁共振成像的开放性初步研究
Arq Gastroenterol. 2014 Jul-Sep;51(3):261-8. doi: 10.1590/s0004-28032014000300017.
7
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
8
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.肥胖症手术可减轻病态肥胖患者非酒精性脂肪性肝炎的特征。
Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6. doi: 10.1053/j.gastro.2015.04.014. Epub 2015 Apr 25.
9
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.幽门螺杆菌感染可能在非酒精性脂肪性肝病的肝细胞气球样变中起潜在作用。
J Gastroenterol. 2015 Sep;50(9):996-1004. doi: 10.1007/s00535-015-1039-2. Epub 2015 Jan 28.
10
TA allele of rs2070673 in the CYP2E1 gene is associated with lobular inflammation and nonalcoholic steatohepatitis in patients with biopsy-proven nonalcoholic fatty liver disease.细胞色素P450 2E1(CYP2E1)基因中rs2070673的TA等位基因与经活检证实的非酒精性脂肪性肝病患者的小叶炎症和非酒精性脂肪性肝炎相关。
J Gastroenterol Hepatol. 2021 Oct;36(10):2925-2934. doi: 10.1111/jgh.15554. Epub 2021 Jun 6.

引用本文的文献

1
Persistently Active Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease.持续活跃感染与代谢功能障碍相关脂肪性肝病的发生有关。
J Clin Med. 2025 Feb 7;14(4):1073. doi: 10.3390/jcm14041073.
2
Potential mechanisms and therapeutic prospects of the association between infection and metabolic dysfunction-associated steatohepatitis.感染与代谢功能障碍相关脂肪性肝炎之间关联的潜在机制及治疗前景
World J Hepatol. 2025 Jan 27;17(1):101798. doi: 10.4254/wjh.v17.i1.101798.
3
Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with infection: A population-based study.

本文引用的文献

1
Relationship Between Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study.发展中国家感染与非酒精性脂肪性肝病(NAFLD)的关系:一项横断面研究
Diabetes Metab Syndr Obes. 2020 Mar 2;13:619-625. doi: 10.2147/DMSO.S237866. eCollection 2020.
2
Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents.非酒精性脂肪性肝病的治疗:从成人试验到儿童和青少年管理的视角
Expert Opin Pharmacother. 2020 Feb;21(3):247-251. doi: 10.1080/14656566.2019.1702967. Epub 2020 Jan 1.
3
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
感染患者中与代谢功能障碍相关脂肪性肝炎相关的患病率及危险因素:一项基于人群的研究。
World J Hepatol. 2024 Oct 27;16(10):1169-1176. doi: 10.4254/wjh.v16.i10.1169.
4
The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease.幽门螺杆菌感染与 rs738409PNPLA3 在代谢功能障碍相关脂肪性肝病中的相互作用。
PLoS One. 2024 Sep 23;19(9):e0310361. doi: 10.1371/journal.pone.0310361. eCollection 2024.
5
Helicobacter pylori infection is associated with liver fibrosis in patients with obesity undergoing bariatric surgery.幽门螺杆菌感染与接受减肥手术的肥胖患者的肝纤维化有关。
JGH Open. 2024 Sep 12;8(9):e70023. doi: 10.1002/jgh3.70023. eCollection 2024 Sep.
6
Association between Helicobacter pylori infection, MASLD, and liver fibrosis in patients with severe obesity: a single-center experience.严重肥胖患者中幽门螺杆菌感染、MASLD 和肝纤维化之间的关系:单中心经验。
Surg Endosc. 2024 Nov;38(11):6873-6879. doi: 10.1007/s00464-024-11177-z. Epub 2024 Aug 27.
7
Bidirectional relationship between infection and nonalcoholic fatty liver disease: insights from a comprehensive meta-analysis.感染与非酒精性脂肪性肝病之间的双向关系:一项全面荟萃分析的见解
Front Nutr. 2024 Aug 5;11:1410543. doi: 10.3389/fnut.2024.1410543. eCollection 2024.
8
The Role of and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes.与代谢综合征相关的肥大细胞激活病理机制的作用及其对妊娠和新生儿结局的潜在影响。
J Clin Med. 2024 Apr 18;13(8):2360. doi: 10.3390/jcm13082360.
9
Helicobacter pylori infection increases the risk of nonalcoholic fatty liver disease: Possible relationship from an updated meta-analysis.幽门螺杆菌感染增加非酒精性脂肪性肝病的风险:来自更新的荟萃分析的可能关系。
Medicine (Baltimore). 2023 Aug 18;102(33):e34605. doi: 10.1097/MD.0000000000034605.
10
The possible role of Helicobacter pylori in liver diseases.幽门螺杆菌在肝脏疾病中的可能作用。
Arch Microbiol. 2023 Jul 11;205(8):281. doi: 10.1007/s00203-023-03602-z.
FLIP算法和SAF评分在非酒精性脂肪性肝病患者中的临床验证。
J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17.
4
Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome.幽门螺杆菌感染可能通过促进肝功能损伤、糖代谢、脂代谢、炎症反应和代谢综合征来加重非酒精性脂肪性肝病的严重程度。
Eur J Gastroenterol Hepatol. 2020 Jul;32(7):857-866. doi: 10.1097/MEG.0000000000001601.
5
Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis.幽门螺杆菌感染与非酒精性脂肪肝之间的关联:一项荟萃分析。
Medicine (Baltimore). 2019 Nov;98(44):e17781. doi: 10.1097/MD.0000000000017781.
6
Comparison of stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of infection in children.粪便抗原、唾液IgG、血清IgG和血清IgM作为儿童感染诊断标志物的比较。
Iran J Microbiol. 2019 Jun;11(3):206-211.
7
Relevance between Helicobacter Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran.伊朗比尔詹德幽门螺杆菌感染与非酒精性脂肪性肝病之间的相关性
J Med Life. 2019 Apr-Jun;12(2):168-172. doi: 10.25122/jml-2019-0012.
8
Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?幽门螺杆菌感染与非酒精性脂肪性肝病:四项荟萃分析支持一种引人关注的关联,这是否指向了正确的方向?
Metabolism. 2019 Jul;96:iii-v. doi: 10.1016/j.metabol.2019.05.006. Epub 2019 May 20.
9
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis.幽门螺杆菌感染与非酒精性脂肪性肝病风险的关系:一项更新的荟萃分析。
Metabolism. 2019 Jul;96:56-65. doi: 10.1016/j.metabol.2019.04.012. Epub 2019 Apr 29.
10
Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.幽门螺杆菌感染与胃肠道癌症生物学:审视一把双刃剑的影响
Cell Mol Life Sci. 2019 Jul;76(13):2487-2488. doi: 10.1007/s00018-019-03106-4. Epub 2019 Apr 20.